Impact of Mulberry Consumption on Glycemic Indices and Lipid Profiles: An Umbrella Review
Open Access
- 13 November 2026
- journal article
- review article
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (11) , e72557
Abstract
The growing worldwide prevalence of type 2 Diabetes Mellitus (T2D) and dyslipidemia requires the identification of effective plant‐based management approaches, including the use of mulberry. However, the clinical evidence about the effects of mulberry on glucose and lipid profiles is inconsistent. This umbrella review studied evidence from five meta‐analyses (MAs) to comprehensively evaluate the impact of mulberry on glycemic and lipid profiles. Systematic searches were performed across major databases with methodological quality and certainty of evidence examined using AMSTAR‐2 and GRADE criteria, respectively. Low‐certainty evidence suggested that mulberry twig alkaloids reduced glycated hemoglobin (HbA1c) in adults with T2D compared with placebo (MD: −0.51%, 95% CI: −0.92 to −0.09). Moderate‐certainty evidence demonstrated that mulberry consumption significantly reduced fasting blood glucose (MD: −34.23 mg/dL, 95% CI: −55.13 to −13.33) and triglycerides (MD: −45.17 mg/dL, 95% CI: −70.86 to −19.49) in adults with T2D. In adults with medical conditions, mulberry also reduced total cholesterol (MD: −13.13 mg/dL; 95% CI: −19.06 to −7.20) and LDL‐C (MD: −8.84 mg/dL; 95% CI: −13.26 to −4.42), with low‐certainty evidence. By contrast, mulberry intake was not associated with changes in fasting plasma insulin and HDL‐C. All five MAs were rated as having critically low methodological quality according to AMSTAR‐2. Therefore, while mulberry may offer potential as a supportive supplement for cardiometabolic management, these findings should be interpreted with caution, are considered preliminary given the critically low methodological quality and the low‐to‐very‐low certainty of evidence for several statistically significant findings, and high‐quality clinical research is needed to strengthen the evidence base.Keywords
This publication has 24 references indexed in Scilit:
- Phytochemicals and metabolic disorders: managing diabetes, obesity, and metabolic syndrome2025
- Effect of mulberry leaf or mulberry leaf extract on glycemic traits: a systematic review and meta-analysisFood & Function, 2022
- Impact of mulberry consumption on cardiometabolic risk factors: A systematic review and meta‐analysis of randomized‐controlled trialsJournal of Clinical Pharmacy and Therapeutics, 2022
- Morus alba L. for Blood Sugar Management: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothBMJ, 2017
- A Six-Month Supplementation of Mulberry, Korean Red Ginseng, and Banaba Decreases Biomarkers of Systemic Low-Grade Inflammation in Subjects with Impaired Glucose Tolerance and Type 2 DiabetesEvidence-Based Complementary and Alternative Medicine, 2012
- Potential mechanisms of hypocholesterolaemic effect of Thai spices/dietary extractsNatural Product Research, 2011
- Intake of 1-Deoxynojirimycin Suppresses Lipid Accumulation through Activation of the β-Oxidation System in Rat LiverJournal of Agricultural and Food Chemistry, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008